A testable hypothesis in a "borderline" neoplasm

American Journal of Dermatopathology

Volumn 24, Issue 1, 2002, Pages 89-91

  LeBoit, Philip E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSPLASTIC NEVUS; GENETIC PROCEDURES; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; MELANOCYTE; PRIORITY JOURNAL; TAXONOMY;

DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; DYSPLASTIC NEVUS SYNDROME; HUMANS; MELANOCYTES; MOLECULAR BIOLOGY; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 0036159623     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200202000-00019     Document Type: Article

References (8)

1. Epithelioid blue nevus: Neoplasm sui generis or variation on a theme
2. Gene expression profile analysis by DNA microarrays: Promise pitfalls
3. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization
4. Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus
5. Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma
6. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma
7. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features